decisionhealth Newsletters, Coder Pink Sheets - 2009 Issue 8 (August)
MedImmune expands financial assistance for Synagis
Subscribe or sign in to view the full article.
Article Overview
This article explains an expanded patient assistance program for Synagis and discusses the broader billing context for RSV prevention in pediatric patients. It is aimed at pediatricians, coders, and billing staff who need to understand coverage assistance, preauthorization, and the general diagnosis categories associated with RSV immunoprophylaxis. The article also summarizes a debate over the clinical and economic value of RSV prophylaxis and points readers to an official pediatric reference resource.
Why This Topic Matters
It helps practices understand assistance options for an expensive RSV-prevention therapy and recognize the broad diagnosis categories and administrative issues commonly tied to billing for it.
Article Sections
-
Patient assistance expansion
Summarizes the manufacturer’s expanded financial assistance program and the kinds of households that may qualify. It also notes where practices can seek reimbursement-related help.
-
Coding for Synagis
Reviews billing and coverage considerations for the office-administered RSV prevention drug and highlights the associated diagnosis categories discussed in the article. The section also identifies related coding references that distinguish this therapy from a similar respiratory syncytial virus product.
-
Debate over Synagis benefits
Provides a high-level summary of the article’s discussion of RSV burden, pediatric reference guidance, and the ongoing debate about the therapy’s value. It presents the broader clinical and economic context without giving coding instructions.
-
Official resource
Points readers to an external pediatric reference page for additional information on RSV prevention guidance.
What You Will Learn
- How the article frames expanded patient assistance for an RSV prevention therapy
- What general billing and preauthorization topics are discussed for office-administered Synagis
- Which broad diagnosis categories are cited in relation to RSV immunoprophylaxis
- What clinical and economic issues are raised in the discussion of RSV prophylaxis
- Where the article directs readers for an official pediatric reference resource
Who Should Read This
- Pediatricians
- Medical coders
- Billing staff
- Practice managers
- Reimbursement specialists
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com